Dr. Golshani Dev WP (throwaway)

Tag: breast implants

  • Breast Augmentation: Build a Responsibility Profile Before a Consultation

    Breast Augmentation: Build a Responsibility Profile Before a Consultation

    Define the Terms Before Assigning Responsibilities

    Breast augmentation is surgery intended to increase breast size. Although people often use “breast augmentation” and “breast implants” as if they mean the same thing, they describe different things: augmentation is the procedure, while implants are prosthetic devices that may be used during it.

    That distinction matters before you decide whether to book a consultation. The first question is not simply, “Which implant should I get?” It is, “What change am I hoping to discuss, and which approach might fit that conversation?” Implant-based augmentation is one pathway, but it is not the only one. Fat transfer and a discussion of breast lift surgery may also be relevant depending on the change a person wants to explore.

    General information can help you arrive prepared to discuss those pathways. It cannot determine whether surgery is appropriate for you, select an approach, predict a visual result, or replace a clinical assessment. Your anatomy, health history, breast tissue, goals, prior procedures, reproductive plans, and tolerance for future care all belong in an individualized conversation with a qualified clinician.

    A useful starting point is to write a short description of your goal without naming a solution: for example, whether you want to discuss added volume, a change in shape, concerns about breast position, or more than one of these. That keeps the consultation centered on the change you want to understand rather than on a device or procedure chosen before the assessment.

    Map the Responsibilities Attached to Each Discussion Pathway

    Use these categories to identify terms that need explanation, not to select a procedure for yourself. A clinical consultation is where their different purposes, trade-offs, and responsibilities can be discussed in relation to your situation.

    Pathway to discuss What it involves Questions and boundaries to carry forward
    Implant-based augmentation In implant-based augmentation, implants are placed under breast tissue or chest muscles. Implant options are commonly described as silicone or saline. Ask how the proposed device, placement, incision, risks, breast screening communication, and long-term follow-up relate to your goals. Implant-specific responsibilities should be part of the decision from the outset.
    Fat transfer Augmentation may also be performed with fat transfer, using fat taken from the body and injected into the breasts. Ask what this method is intended to address in your individual situation and what trade-offs the clinician considers relevant. Do not assume it is interchangeable with implant-based augmentation simply because both are forms of augmentation.
    Breast lift discussion A breast lift is distinct from implant augmentation: it reshapes existing breast tissue and does not itself use implants. If breast position or sagging is part of your concern, ask whether a lift should be discussed alongside or instead of augmentation. Implants do not prevent breast sagging. A clinician may discuss a lift in addition to augmentation after an individual assessment.

    The practical takeaway is that “more volume,” “more upper fullness,” and “a breast position concern” are not automatically the same problem. Rather than treating implants and fat transfer as competing answers, use the consultation to identify the responsibilities and unanswered questions each pathway introduces. A lift has a separate purpose from implant augmentation. Bringing those distinctions into the consultation helps prevent a narrow conversation in which the method is assumed before the goal is clear.

    If you are unsure which pathway applies, that uncertainty is itself worth bringing forward. State what you notice, what you hope to change, and what you do not want to assume. The clinician’s role is to assess the relevant options; your role is to make sure the discussion addresses the questions that matter to you.

    A mindmap showing three breast augmentation discussion pathways: implant-based augmentation, fat transfer, and breast lift discussion.
    Breast augmentation can lead to different consultation pathways, each with its own questions and trade-offs.

    Build a Breast Augmentation Responsibility Profile

    Use this as a responsibility-routing profile, not as a candidacy checklist or a way to compare yourself with another patient. Instead of ranking pathways or predicting an outcome, place each question in the lane that can answer it: general information, individualized clinical planning, or implant-specific device information. Then connect the unresolved questions to the pathway that creates them. The purpose is to prevent a general fact, a device document, or a personal clinical decision from being treated as interchangeable.

    1. Name the question before naming the pathway. Write the change you want to discuss in ordinary language, such as volume, shape, position, or asymmetry. Then create three notes for it: what general information can clarify, what requires individualized clinical planning, and what device information would matter if implants enter the discussion.

    2. Separate the pathways. Keep implant-based augmentation, fat transfer, and a lift discussion in separate entries. For implants, the profile must include device information and long-term care; for fat transfer, it must include the separate questions created by using fat taken from another body area; for a lift, it must preserve the distinction between position and implant-based volume.

    3. Mark plan-dependent responsibilities. Record the incision, placement, and anesthesia questions only as items for clinical explanation. General descriptions can show what needs discussion but cannot establish a plan for you.

    4. Attach device duties only where they belong. If implants are under consideration, add patient-labeling materials, implant-specific complications, breast-screening communication, and the possibility of future procedures. Breast implants are not lifetime devices, and future surgery may be needed for reasons including rupture or changes in the breasts or body.

    5. Record life considerations separately. Keep breastfeeding questions and practical recovery-support questions distinct from device information. Breastfeeding after augmentation is possible for some people but can be challenging for others.

    6. Test the routing, not just the list. Ask whether each entry is assigned to the right answer source: general explanation, clinician discussion, or approved device labeling. If travel or distance could affect care, place continuity and follow-up questions in the clinician-discussion lane rather than assuming an arrangement.

    7. Set a discussion boundary. End with the responsibility you would need explained before deciding whether to continue exploring that pathway. An unresolved material responsibility is a reason to seek clarification, not a conclusion about suitability.

    This profile does not tell you which option to choose. It helps you test whether you understand the terms, uncertainties, and responsibilities well enough to have a more informed clinical conversation. Signed documentation alone may not establish understanding; ask for clarification when you cannot explain a material point in your own words.

    Reserve Surgical-Plan Choices for Individual Explanation

    It is tempting to turn procedural details into preferences before meeting a clinician. In practice, they are planning questions. The cited clinical source lists incision locations at the breast crease, under the arm, and around the nipple. It also notes that anesthesia planning varies: local anesthesia may be used, while general anesthesia is often used.

    Those facts are useful because they show that breast augmentation is not a single, standardized sequence of choices. They are not a basis for choosing an incision or anesthesia plan for yourself. The relevant decision depends on the procedure being discussed and on individual clinical planning.

    Use the consultation to ask direct, bounded questions: Which incision locations are being considered in my case? What factors are shaping that discussion? What anesthesia approach is planned, and who will explain its role? What should I understand about the surgical plan before consenting? Ask for explanations in language you can repeat back. A clear answer should help you understand the proposed plan and its rationale, not merely give you a term to search online.

    It is also reasonable to pause if a material choice remains unclear. Elective surgery allows room to seek clarification, review information, and decide whether you understand the proposed approach well enough to proceed.

    Add Implant-Specific Safety Responsibilities to the Profile

    For someone considering implant-based augmentation, safety is not a short disclosure at the end of the consultation. It is part of deciding whether the pathway fits your priorities. In the United States, the FDA lists breast pain, changes in nipple or breast sensation, additional surgery, capsular contracture, rupture or deflation, and possible breastfeeding impact among implant risks and complications.

    Some terms deserve plain-language discussion. FDA defines capsular contracture as tightening of tissue around an implant that can cause firmness or hardening and, when severe, squeeze the implant. FDA defines rupture as a tear or hole in an implant’s outer shell. FDA states that severe capsular contracture may require reoperation and can recur after corrective surgery.

    The FDA also identifies BIA-ALCL, a type of non-Hodgkin lymphoma, among breast-implant-associated risks. It lists reports of squamous cell carcinoma, lymphomas other than BIA-ALCL, and mesenchymal tumors including sarcoma among breast-implant concerns. These are consequential topics to review carefully in a device-specific conversation; they should not be minimized, generalized into a prediction about an individual, or treated as a reason to skip informed discussion.

    Long-term planning also includes the possibility of later procedures.

    FDA directs readers to approved implant patient labeling for complete complication lists and rates. Ask for the patient labeling for any implant under discussion and review it before making a final decision. In 2021, FDA strengthened breast-implant risk-communication requirements, including sales and distribution restrictions intended to support informed decisions.

    A productive consultation question is not “Will I need another surgery?” because no one can promise a personal answer. Ask instead: “What future procedures might become relevant, what circumstances could lead to them, and what does the device labeling say about complications and rates?” That question keeps uncertainty visible without converting it into either reassurance or alarm.

    Keep Variable Implant Lifespan and Consent Questions Visible

    Do not treat an implant as a lifetime purchase with a fixed expiration date. Available clinical information gives different typical estimates—about 10 years in one source and about 10–15 years for possible replacement or revision in another—so implant lifespan should be treated as variable rather than fixed. The same source notes that rupture and changes in the breasts or body can lead to further surgery. The more useful planning stance is to understand that implant-based augmentation can involve long-term attention and that future decisions may be necessary.

    Meaningful consent is more than signing a form. The cited informed-consent article describes inconsistency in cosmetic-surgery consent practices and cautions that signed documentation alone may not establish understanding. If you cannot explain the proposed procedure, alternatives, material risks, expected follow-up, and future-care responsibilities in your own words, ask for a slower explanation.

    In one international respondent survey, 63.2% reported two face-to-face consultations with physical examination before cosmetic surgery, while 31.2% reported one. This describes respondents’ practices, not a universal requirement. Likewise, most respondents believed the performing surgeon should be responsible for consent and postoperative management, including in surgical-tourism cases; that is a survey finding rather than a universal legal or clinical standard.

    For a reader, the practical lesson is straightforward: prioritize continuity, clarity, and enough time to consider what you have learned. If travel is part of your plan, ask specifically who handles postoperative management, how follow-up is arranged, and what information should travel with you. Do not rely on an online exchange alone to settle questions that require physical examination and individualized planning.

    Turn the Responsibility Profile Into a Consultation Agenda

    Before scheduling or after a consultation, use a short written routing agenda organized by answer source and pathway. You do not need to know the answers in advance. Its purpose is to show which points belong in general education, which require individualized explanation, which should be checked against implant labeling, and which pathway-specific responsibilities remain unresolved.

    • What change do I want to discuss, and what responsibility might that discussion introduce without selecting a procedure in advance?
    • Which pathway is being discussed—implant-based augmentation, fat transfer, or a lift—and what purpose does each term describe?
    • If implants are under consideration, what device information and patient labeling should I review?
    • Which responsibilities belong specifically to the implant, including capsular contracture, rupture or deflation, sensation changes, breast screening communication, and possible additional surgery?
    • What questions about fat transfer or a lift should remain separate from implant responsibilities?
    • Which incision, placement, and anesthesia choices require an individualized explanation?
    • What recovery-support, follow-up, and continuity questions remain unanswered?
    • What future revision or removal possibilities should I understand without treating them as a prediction?
    • Which responsibility would I need explained before deciding whether to continue exploring this pathway?

    A useful consultation should help you complete your responsibility profile by showing which pathway is being discussed, what responsibilities it creates, and which questions remain individualized. Take time to review device information when implants are discussed, keep alternatives distinct, and pause when you cannot explain a material part of the proposed plan to your satisfaction.


    Frequently Asked Questions About Breast Augmentation Responsibilities

    What is the difference between breast augmentation and breast implants?

    Augmentation is the procedure intended to increase breast size, while implants are the prosthetic devices often used in that procedure. The terms are often used together, but they are not the same thing.

    What options are usually discussed besides implant-based augmentation?

    Fat transfer and a breast lift may also come up, depending on the change you want to discuss. Each pathway has different trade-offs, so it helps to clarify whether your main concern is volume, shape, position, or more than one of these.

    What should I ask about implant safety if implants are part of the discussion?

    Ask about the risks and complications that are most relevant to the specific device and plan being discussed, including capsular contracture, rupture or deflation, sensation changes, and the possibility of additional surgery. It is also reasonable to ask for the patient labeling and to review it before deciding.

    Will implants stop breast sagging?

    No. Implants do not prevent sagging. If breast position is part of your concern, a clinician may discuss whether a lift should be considered along with or instead of augmentation after an individual assessment.

    What long-term issues should I bring up if I am considering surgery?

    Plan to discuss breast screening, possible future procedures, and any breastfeeding concerns that matter to you. Breast implants may require additional mammographic views, and future surgery can become relevant if the implant or breast changes over time.


  • Breast Augmentation Decision Guide: Goals, Trade-Offs, and Revision Questions

    Breast Augmentation Decision Guide: Goals, Trade-Offs, and Revision Questions

    Decide What You Want Breast Augmentation to Address

    It can use breast implants or fat transfer to increase breast size. People may consider it to restore volume after weight reduction or pregnancy, create a rounder shape, or address natural differences in breast size. The first decision is therefore not simply which implant to choose. It is whether the change you want is primarily about volume, shape, asymmetry, or a combination of concerns.

    A useful consultation begins with a short written description of your goal. For example: “I want more upper-breast fullness,” “I want to restore volume after pregnancy,” or “I want to address asymmetry.” Avoid treating a desired cup size as the entire plan; your surgeon will need to relate your goal to your anatomy, available tissue, and the procedure options that may be appropriate for you.

    This guide is for preparing questions, not determining candidacy or selecting treatment. Bring your goals, concerns, and willingness to accept long-term responsibilities to a qualified plastic surgeon. The discussion should cover both the appearance you hope to change and the trade-offs involved in achieving it.

    Test Your Goal Against the Procedure’s Limits

    Augmentation is not a universal solution for every breast-shape concern. Breast augmentation does not correct severely drooping breasts. When sagging is a significant part of the concern, a surgeon may discuss whether a breast lift should be performed alongside augmentation.

    This distinction matters because adding volume and lifting the breast address different aspects of appearance. If your main concern is loss of fullness, augmentation may be the central topic. If your concern is that the breast sits lower, the nipple position has changed, or the skin envelope feels substantially stretched, ask directly whether augmentation alone addresses that concern. Do not assume that a larger implant will substitute for a lift.

    Use these questions to define the boundary of your goal:

    • Is my primary concern volume, shape, asymmetry, sagging, or several of these?
    • Would augmentation alone address the concern I am describing?
    • Should a breast lift be discussed, and if so, how would that change the procedure and its trade-offs?
    • Would fat transfer be relevant to my stated goal, or is an implant discussion more appropriate?

    The practical next step is to ask the surgeon to separate what augmentation may address from what it cannot address by itself. That keeps the consultation focused on your actual concern rather than on a presumed procedure.

    Build Your Goals, Trade-Offs, and Long-Term Responsibilities Worksheet

    Bring a two-part worksheet to the consultation. The first part connects your desired change to surgical planning. The second addresses the responsibilities that continue after surgery.

    Part one: goals and planning

    Write down the change you want, how subtle or noticeable you want it to be, and any concerns about symmetry, shape, scars, or future activity. Then ask:

    • What options could address my goal: implants, fat transfer, augmentation with a lift, or another approach?
    • How do my anatomy and body type affect the available options?
    • What implant characteristics, if any, should we compare, and what are their relevant benefits and risks?
    • Where would an incision be considered, and how does incision planning relate to implant type, desired enlargement, anatomy, and surgeon preference?
    • How would implant insertion and positioning be planned for my body type and desired enlargement?
    • What recovery restrictions and follow-up visits should I plan for, and which aspects of recovery are individualized?

    Incision planning varies with the implant type, the enlargement sought, anatomy, and patient-surgeon preference. Implant placement planning likewise depends on the implant, desired enlargement, body type, and the surgeon’s recommendations. These are consultation decisions, not choices that can be made responsibly from a general guide.

    Part two: long-term responsibilities

    Add questions about device-specific labeling, monitoring, breast-cancer screening, possible reoperation, and financial responsibility. Ask the surgeon to identify which recommendations apply to the implant option under discussion and what costs may arise over time.

    Before deciding, review the manufacturer’s patient labeling and educational materials, and discuss questions with the surgeon. In the United States, the FDA requires a device-specific Patient Decision Checklist describing known or reported risks. Ask to review the checklist for the specific device being considered, rather than relying on general descriptions of implants.

    The worksheet is complete when you can explain your goal, the planning variables that may affect the procedure, the risks you have discussed, the follow-up you may need, and the questions you still want answered. It is a preparation tool, not a prediction of your result or recovery.

    Weigh Risks, Financial Responsibilities, and Possible Future Surgery

    The central long-term trade-off is that breast implants are not lifetime devices. FDA says that the longer implants are in place, the more likely removal or replacement becomes, and advises prospective patients to assume that additional operations may be needed over time. That possibility should be part of the decision before an initial procedure, not considered only if a problem develops.

    FDA identifies capsular contracture, reoperation, and implant removal among the most common local complications and adverse outcomes. Other listed local complications include rupture or deflation, wrinkling, asymmetry, scarring, pain, and infection at the incision site. The list describes possible complications, not a prediction that any particular patient will experience them.

    Financial planning also belongs in the risk discussion. FDA notes that insurance may not cover implant removal or replacement, including when complications occur. Ask for a clear explanation of anticipated surgical, facility, anesthesia, device, imaging, medication, and follow-up costs. Ask separately what happens financially if an implant must be removed, replaced, or revised.

    A responsible decision does not require certainty that every future event can be predicted. It does require accepting that implants may involve future monitoring, complications, additional operations, and expenses.

    Plan for Monitoring, Screening, and Changes That Need Evaluation

    Implants need monitoring for as long as they remain in place. If silicone gel-filled implants are being considered, confirm with your health care provider whether regular ultrasound or MRI monitoring is recommended and whether that monitoring is covered by insurance. The appropriate schedule and imaging decisions should come from your health care provider.

    Breast implants also affect how you communicate about breast-cancer screening. Follow your provider’s instructions for screening and tell the mammography facility that you have implants when making an appointment. Clarify with the facility what to expect for mammography with implants.

    Make a plan for contacting a surgeon or other health care provider if you notice abnormal changes in your breasts or implants.
    These points are not an emergency diagnosis or a substitute for medical evaluation. They are questions to place in your long-term-responsibility section:

    • What monitoring do you recommend for the specific implant being discussed?
    • How should I coordinate implant monitoring with breast-cancer screening?
    • What changes should prompt a call, and whom should I contact?
    • What imaging, evaluation, or follow-up costs should I anticipate?

    Leave the consultation with a written follow-up plan and a clear route for raising concerns.

    Review Device-Specific Information Before You Decide

    Implant decisions should be based on the labeling and risk information for the specific device under consideration. Review the manufacturer’s patient labeling and educational materials, then discuss questions with the surgeon before deciding. The Patient Decision Checklist is intended to support that discussion by presenting known or reported risks for the device.

    One risk that should be addressed directly is BIA-ALCL. FDA describes it as a cancer of the immune system that can occur in the breast or scar tissue surrounding an implant; it is not breast cancer. ASPS notes that BIA-ALCL occurs most frequently in patients with textured-surface implants. Ask which implant surfaces and characteristics are being considered, why, and what information applies to each option.

    Useful questions include:

    • Can I review the manufacturer’s current patient labeling for this device?
    • Can we go through the device-specific Patient Decision Checklist together?
    • What is known about the device’s surface, rupture or deflation concerns, monitoring, and possible reoperation?
    • What symptoms or changes should lead me to contact the practice?
    • Which risks are specific to this device, and which are general surgical risks?

    The goal is not to memorize every complication. It is to understand the device-specific information well enough to make a deliberate decision and to know what follow-up responsibilities may continue after surgery.

    Confirm the Stated Revision Assurance Terms in Writing

    Golshani Plastic Surgery states that a 90-day Revision Assurance Program is available for breast augmentation at its Beverly Hills location. The stated terms limit it to primary procedures performed at that office, not procedures performed elsewhere or by another surgeon. The practice also states that patients dissatisfied within 90 days of the original surgery date may be eligible for one revision and that the standard surgeon’s fee is waived.

    Treat these as practice-stated terms that require current written confirmation. The supplied policy information does not establish that every revision-related expense is covered. In particular, do not assume that facility, anesthesia, implant, medication, pathology, imaging, or other costs are included in the surgeon-fee waiver.

    Ask these questions before relying on the program in your decision:

    • Is the program currently effective, and can I receive the complete written policy?
    • Does it apply to my planned primary procedure at the Beverly Hills office?
    • How is the 90-day period calculated, and what notice or evaluation process is required?
    • What does “one revision” mean, and who determines whether a revision is indicated or eligible?
    • Does the waiver cover only the standard surgeon’s fee?
    • Which facility, anesthesia, implant, medication, pathology, imaging, or other costs remain my responsibility?
    • What exclusions, circumstances, timing requirements, or documentation rules apply?
    • What happens if I receive care at another location or from another surgeon?

    The program should be one item in a broader decision, not a substitute for risk counseling or a guarantee of a particular aesthetic result, satisfaction, candidacy, or coverage. Obtain the current terms and exclusions in writing during consultation.

    Make a More Informed Consultation Decision

    This procedure may align with your goals if you can clearly describe the change you want and are prepared to discuss its limits, planning variables, risks, monitoring, possible future operations, and financial responsibilities. A consultation is a reasonable next step when you want individualized answers—but it should leave you with informed questions, not pressure to decide immediately.

    Bring the completed worksheet, manufacturer information, and the written questions about the stated Revision Assurance Program. Use the consultation to determine whether the proposed approach addresses your concern, what trade-offs it involves, and which terms and follow-up responsibilities apply to you. A consultation can support individualized discussion, but it does not guarantee candidacy, outcomes, safety, satisfaction, or eligibility for revision coverage.


    Frequently Asked Questions About Preparing for Breast Augmentation

    What does breast augmentation involve?

    It is a procedure that uses breast implants or fat transfer to increase breast size.

    How do surgeons decide between implants, fat transfer, or a lift?

    That depends on the change you want, your anatomy, and the concern being addressed. If sagging is a major issue, a surgeon may discuss whether a breast lift should be part of the plan rather than augmentation alone.

    Are breast implants considered permanent?

    No. FDA states that breast implants are not lifetime devices, so additional surgery may be needed over time. The possibility of removal or replacement should be part of the decision from the start.

    What follow-up is usually discussed after breast augmentation?

    Follow-up usually includes ongoing monitoring while implants are in place, plus guidance on screening and what changes should prompt a call. If silicone gel-filled implants are being considered, ask whether ultrasound or MRI monitoring is recommended and how it is handled.

    What should I clarify about the Beverly Hills revision program?

    Ask for the current written terms and confirm whether the program applies to a primary procedure at that office. Also clarify the 90-day window, the one-revision limit, whether only the surgeon’s fee is waived, and which other costs would still be your responsibility.